 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Device Dossier for Insurers Please review a PDF of our dossier below for details. The guide is intended to provide background information on the LacriCATH® balloon catheter for dacryoplasty (DCP) for providers and insurers to make appropriate coverage and payment decisions. It is NOT intended to increase or maximize coverage or reimbursement. The document is not intended as legal advice. Seek legal counsel or a reimbursement specialist for further questions. The provider and/or insurer makes all decisions concerning requirements for claims submission, coverage, and reimbursement. The document is for information purposes only and represents no statement, promise, or guarantee concerning levels of reimbursement, payment or charges. Thank you for your interest in and consideration of coverage and reimbursement for the LacriCATH® balloon catheter used in the treatment of nasolacrimal duct obstruction. This Device Dossier for LacriCATH® is intended to provide extensive information on all aspects of the LacriCATH® balloon catheter. It contains the most recently available information related to FDA clearance, coding, procedure description, and peer-reviewed literature. The LacriCATH® is available in a unilateral or bilateral procedure kit. Each kit includes a 2mm or 3mm catheter (two catheters in the bilateral kit), a 10cc single-use inflation device, and a 4-way stopcock (in the bilateral kit only) for simultaneous bilateral inflation. Pricing is available by contacting the manufacturer. If you have any questions or if there is additional information you would like to review, please contact us at 800-627-0226 ext 520. Sincerely, Product Orders & Information: (800) 627-0226 LacriCATH Advantages | LacriCATH Procedures | Product List
|
|
